Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system
Source abstract
Abstract
A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin-loaded TCPB nanoparticles (DOXO-TCPB) to be internalized into cancer cells by CD44 receptor mediated uptake was assessed by means of uptake studies in HCT cells. These data were supported by anti-CD44-FITC staining assay. The proposed TCPB nanostructured drug delivery systems have many potential applications in nanomedicine, including cancer targeted drug delivery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Proteoglycans and glycosaminoglycans research · Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Cappelli A, Pericot Mohr G, Anzini M, Vomero S, Donati A, Casolaro M, Mendichi R, Giorgi G, Makovec F (2003) Synthesis and characterization of a new benzofulvene polymer showing a thermoreversible polymerization behavior. J Org Chem 68:9473–947610.1021/jo035104h ↗
2. Cappelli A, Galeazzi S, Giuliani G, Anzini M, Aggravi M, Donati A, Zetta L, Boccia AC, Mendichi R, Giorgi G, Paccagnini E, Vomero S (2008) Anionic polymerization of a benzofulvene monomer leading to a thermoreversible π-stacked polymer. Studies in macromolecular and aggregate structure. Macromolecules 41:2324–233410.1021/ma702319h ↗
3. Cappelli A, Galeazzi S, Giuliani G, Anzini M, Grassi M, Lapasin R, Grassi G, Farra R, Dapas B, Aggravi M, Donati A, Zetta L, Boccia AC, Bertini F, Samperi F, Vomero S (2009) Synthesis and spontaneous polymerization of oligo(ethylene glycol)-conjugated benzofulvene macromonomers. A polymer brush forming a physical hydrogel. Macromolecules 42:2368–237810.1021/ma802429g ↗
4. Cappelli A, Paolino M, Grisci G, Giuliani G, Donati A, Mendichi R, Boccia AC, Samperi F, Battiato S, Paccagnini E, Giacomello E, Sorrentino V, Licciardi M, Giammona G, Vomero S (2011) A click chemistry-based “grafting through” approach to the synthesis of a biorelevant polymer brush. Polym Chem 2:2518–252710.1039/c1py00271f ↗
5. Cappelli A, Paolino M, Grisci G, Giuliani G, Donati A, Mendichi R, Boccia AC, Botta C, Mróz W, Samperi F, Scamporrino A, Giorgi G, Vomero S (2012) Synthesis and characterization of charge-transporting π-stacked polybenzofulvene derivatives. J Mater Chem 22:9611–962310.1039/c2jm16790e ↗
6. Cappelli A, Grisci G, Paolino M, Castriconi F, Giuliani G, Donati A, Lamponi S, Mendichi R, Boccia AC, Samperi F, Battiato S, Paccagnini E, Gentile M, Licciardi M, Giammona G, Vomero S (2013) Combining spontaneous polymerization and click chemistry for the synthesis of polymer brushes: a “grafting onto” approach. Chem Eur J 19:9710–972110.1002/chem.201202534 ↗
7. Cappelli A, Grisci G, Paolino M, Razzano V, Giuliani G, Donati A, Bonechi C, Mendichi R, Boccia AC, Licciardi M, Scialabba C, Giammona G, Vomero S (2015) Polybenzofulvene derivatives bearing dynamic binding sites as potential anticancer drug delivery systems. J Mater Chem B 3:361–37410.1039/C4TB01268B ↗
8. Cappelli A, Paolino M, Grisci G, Razzano V, Giuliani G, Donati A, Bonechi C, Mendichi R, Battiato S, Samperi F, Scialabba C, Giammona G, Makovec F, Licciardi M (2016) Hyaluronan-coated polybenzofulvene brushes as biomimetic materials. Polym Chem 7:6529–654410.1039/C6PY01644H ↗
9. Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micieli D, Sarpietro MG, Pignatello R, Castelli F, Baldini N (2008) Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials 29:1400–141110.1016/j.biomaterials.2007.12.022 ↗
10. Dosio F, Arpicco S, Stella B, Fattal E (2016) Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Del Rev 97:204–23610.1016/j.addr.2015.11.011 ↗
11. Eliaz RE, Szoka FC (2001) Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61:2592–2601
12. Fan X, Zhao X, Qu X, Fang J (2015) pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect. Int J Pharmac 496:644–65310.1016/j.ijpharm.2015.10.066 ↗
13. Hall CL, Turley EA (1995) Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neuro-Oncol 26:221–22910.1007/BF01052625 ↗
14. Knopf-Marques H, Pravda M, Wolfova L, Velebny V, Schaaf P, Vrana NE, Lavalle P (2016) Hyaluronic acid and its derivatives in coating and delivery systems: applications in tissue engineering, regenerative medicine and immunomodulation. Adv Healthcare Mater 5:2841–285510.1002/adhm.201600316 ↗
15. Lee H, Lee K, Park TG (2008) Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem 19:1319–132510.1021/bc8000485 ↗
16. Licciardi M, Grassi M, Di Stefano M, Feruglio L, Giuliani G, Valenti S, Cappelli A, Giammona G (2010) PEG-benzofulvene copolymer hydrogels for antibody delivery. Int J Pharm 390:183–19010.1016/j.ijpharm.2010.02.002 ↗
17. Licciardi M, Amato G, Cappelli A, Paolino M, Giuliani G, Belmonte B, Guarnotta C, Pitarresi G, Giammona G (2012) Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery. Int J Pharm 438:279–28610.1016/j.ijpharm.2012.09.023 ↗
18. Licciardi M, Scialabba C, Sardo C, Cavallaro G, Giammona G (2014) Amphiphilic inulin graft co-polymers as self-assembling micelles for doxorubicin delivery. J Mater Chem B 2:4262–427110.1039/C4TB00235K ↗
19. Luo Y, Bernshaw NJ, Lu ZR, Kopecek J, Prestwich GD (2002) Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res 19:396–40210.1023/A:1015170907274 ↗
20. Manocha B, Margaritis A (2010) Controlled release of doxorubicin from doxorubicin/γ-polyglutamic acid ionic complex. J. Nanomater. Article ID 780171, 9 pages, doi: 10.1155/2010/780171 .10.1155/2010/780171 ↗
21. Mattheolabakis G, Milane L, Singh A, Amiji MM (2015) Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target 23:605–61810.3109/1061186X.2015.1052072 ↗
22. Mauro N, Campora S, Scialabba C, Adamo G, Licciardi M, Ghersi G, Giammona G (2015) Self-organized environment-sensitive inulin–doxorubicin conjugate with a selective cytotoxic effect towards cancer cells. RSC Adv 5:32421–3243010.1039/C5RA00287G ↗
23. Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46:1271–127710.1016/j.ejca.2010.02.024 ↗
24. Pitarresi G, Palumbo FS, Albanese A, Fiorica C, Picone P, Giammona G (2010) Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug. J Drug Target 18:264–27610.3109/10611860903434027 ↗
25. Pitarresi G, Palumbo FS, Calascibetta F, Fiorica C, Di Stefano M, Giammona G (2013) Medicated hydrogels of hyaluronic acid derivatives for use in orthopedic field. Int J Pharmac 449:84–9410.1016/j.ijpharm.2013.03.059 ↗
26. Toole BP, Ghatak S, Misra S (2008) Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol 9:249–25210.2174/138920108785161569 ↗
27. Tripodo G, Trapani A, Torre ML, Giammona G, Trapani G, Mandracchia D (2015) Hyaluronic acid and its derivatives in drug delivery and imaging: recent advances and challenges. Eur J Pharm Biopharm 97:400–41610.1016/j.ejpb.2015.03.032 ↗
28. Turley EA, Noble PW, Bourguignon LY (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277:4589–459210.1074/jbc.R100038200 ↗
29. Unsoy G, Yalcin S, Khodadust R, Gunduz G, Gunduz U (2012) Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanopart Res 14:964–97810.1007/s11051-012-0964-8 ↗
30. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J, Gao F (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287:43094–4310710.1074/jbc.M112.349209 ↗
31. Yin H, Zhao F, Zhang D, Li J (2015) Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery. Int J Pharmac 483:169–17910.1016/j.ijpharm.2015.02.022 ↗
32. Zhao Z, Chen A, Li Y, Hu J, Liu X, Li J, Zhang J, Li G, Zheng Z (2012) Fabrication of silk fibroin nanoparticles for controlled drug delivery. J Nanopart Res 14:736–74610.1007/s11051-012-0736-5 ↗
33. Zhong Y, Goltsche K, Cheng L, Xie F, Meng F, Deng C, Zhong Z, Haag Z (2016) Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials 84:250–26110.1016/j.biomaterials.2016.01.049 ↗